Drug profile · INN
pegunigalsidase alfa
ELFABRIO
pegunigalsidase alfa (ELFABRIO) is a globotriosylceramide hydrolytic enzyme.
EMA: approved Alimentary tract and metabolism (A16) A16AB20
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — pegunigalsidase alfa
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
pegunigalsidase alfa (ELFABRIO) is a globotriosylceramide hydrolytic enzyme.
Key facts
INN pegunigalsidase alfa
Brand ELFABRIO
Mechanism Globotriosylceramide hydrolytic enzyme
Target Globotriosylceramide
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AB20
Mechanism of action
Globotriosylceramide hydrolytic enzyme
Primary target: Globotriosylceramide
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pegunigalsidase alfa?
pegunigalsidase alfa (ELFABRIO) is a globotriosylceramide hydrolytic enzyme.
What is the brand name for pegunigalsidase alfa?
ELFABRIO is a marketed brand name for pegunigalsidase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.